CEO Joseph Woody retires; CFO Michael Greiner named interim CEO; Warren Machan interim CFO

AVANOS MEDICAL, INC.

Joseph Woody retired as CEO and board member effective Oct 28, 2024; will consult through Apr 30, 2025 at $84,618/month.
Michael Greiner (SVP/CFO/CTO) appointed interim CEO; receives $600k salary, $83k/month stipend, and $1M RSU grant.
Warren Machan (former SVP Business Strategy) appointed interim CFO; compensation not yet determined.
Board will conduct a search for permanent CEO; Greiner is leading candidate but will evaluate other candidates.
Company reported Q3 2024 financial results via press release on Oct 30; specific figures not included in this filing.

item 2.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Michael C. Greiner

Interim Chief Executive Officer

AVNS · AVANOS MEDICAL, INC.

Effective: 2024-10-28
Filed: October 30, 2024, 7:59 PM ET

the Company appointed Michael C. Greiner to serve as Interim Chief Executive Officer of the Company.

Departed

Joseph F. Woody

Chief Executive Officer

AVNS · AVANOS MEDICAL, INC.

Effective: 2024-10-28
Successor: Michael C. Greiner
Filed: October 30, 2024, 7:59 PM ET

On October 28, 2024, the Company announced the retirement of Joseph F. Woody as Chief Executive Officer and a member of the Board of Directors of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael C. Greiner was appointed as Interim Chief Executive Officer at AVANOS MEDICAL, INC..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

the Company appointed Michael C. Greiner to serve as Interim Chief Executive Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph F. Woody retired as Chief Executive Officer at AVANOS MEDICAL, INC..

Action: retired
Role: Chief Executive Officer

Exact text from the filing

On October 28, 2024, the Company announced the retirement of Joseph F. Woody as Chief Executive Officer and a member of the Board of Directors of the Company, effective immediately.

View on SEC.gov

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-24-000082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.